As October 2025 dawns, the United Kingdom is actively charting a course for the responsible integration of Artificial Intelligence within its healthcare system. A significant stride in this direction was the launch of the National Commission into the Regulation of AI in Healthcare by the Medicines and Healthcare products Regulatory Agency (MHRA) on September 26, 2025. This isn't just another committee; it's a dedicated, expert advisory body tasked with a crucial mission: to scrutinize existing regulations and forge a robust new framework specifically for AI in healthcare.
The ambition behind this commission is substantial. Bringing together a diverse group of global AI leaders, seasoned clinicians, and experienced regulators, the MHRA aims to receive actionable recommendations. These insights will not only guide the development of interim MHRA guidance, addressing immediate uncertainties like Ambient Voice Technology, but will also lay the groundwork for a comprehensive regulatory framework expected in 2026. This initiative is deeply intertwined with broader governmental strategies, including the 10-Year Health Plan for England and the Life Sciences Sector Plan, both of which champion the transformation of the NHS for patient benefit and the stimulation of economic growth in the UK's life sciences sector.
To ensure this new framework is truly representative and effective, the MHRA has opened a 'Call for Evidence.' This is a vital opportunity for anyone with a stake in AI in healthcare – from industry professionals and researchers to patients and the public – to contribute their perspectives. The insights gathered will be instrumental in shaping the commission's recommendations and tackling the most pressing challenges. The window for submissions remains open until February 2, 2026, underscoring the thoughtful, deliberate approach being taken.
Leading this charge is Professor Alastair Denniston, a practising NHS clinician and head of the UK’s Centre of Excellence in Regulatory Science in AI & Digital Health (CERSI-AI). He's joined by Professor Henrietta Hughes, the Patient Safety Commissioner for England, who brings a critical focus on patient safety and public voice. The commission's membership is a testament to the breadth of expertise being assembled, including leading figures in machine learning, data science, population health research, and health technology leadership. Their collective aim is to ensure that cutting-edge AI technologies can be integrated safely and effectively into the fabric of everyday healthcare, ultimately benefiting patients and strengthening the UK's position in the global AI landscape.
